Share Medexus Announces Strong Fiscal Q2 2027 Results Driven By Record Product-Level Performance of GRAFAPEX (Treosulfan) for Injection

Newsfile Corp · MEDXF · November 11, 2026

Medexus Announces Strong Fiscal Q2 2027 Results Driven By Record Product-Level Performance of GRAFAPEX (Treosulfan) for Injection

Stocks To Buy Now app

Get the app for more

Explore stock news, insights and company research.

Get the app →
Source: Newsfile Corp ↗